Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma
Open Access
- 1 July 1995
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (1) , 183-184
- https://doi.org/10.1038/bjc.1995.299
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Treatment approaches to the low-grade lymphomas.1994
- From triazines and triazenes to temozolomideEuropean Journal Of Cancer, 1993
- Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumoursEuropean Journal Of Cancer, 1993
- Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)British Journal of Cancer, 1992
- ANTITUMOR IMIDAZOTETRAZINES .13. ANTITUMOR-ACTIVITY AND PHARMACOKINETICS IN MICE OF 8-CARBAMOYL-3-METHYL-IMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE (CCRG 81045-M-AND-B-39831), A NOVEL DRUG WITH POTENTIAL AS AN ALTERNATIVE TO DACARBAZINE1987